Tubidy
    Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

    Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

    00:18 |
    Download MP3

    Related Videos

    Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment 0:46

    Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

    Next-Gen Sequencing is Transforming Oncology Practices 4:27

    Next-Gen Sequencing is Transforming Oncology Practices

    Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology 2:41

    Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

    Edward Kim, MD, describes how immunotherapy combinations will be used in the near future 1:36

    Edward Kim, MD, describes how immunotherapy combinations will be used in the near future

    William K. Oh, MD, considers the role of PARP inhibitors in mCRPC 2:37

    William K. Oh, MD, considers the role of PARP inhibitors in mCRPC

    Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists 2:19

    Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

    Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients 0:58

    Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

    Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study 0:41

    Debu Tripathy, MD, on the use of hormonal therapy in the PALOMA-2 clinical study

    Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making 2:20

    Daniel M. Geynisman, MD, on how real-world analysis influences clinical decision-making

    Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors 0:54

    Debra Patt, MD, PhD, MBA, on the promising investigations of CDK4/6 inhibitors

    Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting 0:50

    Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

    Jeff Vacirca, MD, explains why OneOncology is a unique practice model 0:52

    Jeff Vacirca, MD, explains why OneOncology is a unique practice model

    Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care 1:59

    Bo Gamble, compares and contrasts the definition of value and quality as it relates to cancer care

    Will NGS-Based Cancer Tests Become Routine? 3:23

    Will NGS-Based Cancer Tests Become Routine?

    Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer 2:55

    Christopher J. Kane MD, FACS, on trends in the multimodality treatment of localized prostate cancer

    Russell Gollard, MD, explains how IDNs effectively coordinate cancer care 1:44

    Russell Gollard, MD, explains how IDNs effectively coordinate cancer care

    The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD 0:37

    The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

    Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer 1:12

    Erika Hamilton, MD, on how CDK4/6 inhibitors transformed the management of metastatic breast cancer

    Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer 5:14

    Dana Chase, MD, shares details about PRIMA and PAOLA clinical studies regarding ovarian cancer

    Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields 0:19

    Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields